Attached files
file | filename |
---|---|
EX-99.1 - NEUROGESX ENGAGES JSB-PARTNERS TO EXECUTE BUSINESS DEVELOPMENT STRATEGY - NeurogesX Inc | d336816dex991.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
April 19, 2012 (April 17, 2012)
Date of Report (date of earliest event reported)
NEUROGESX, INC.
(Exact name of Registrant as specified in its charter)
Delaware | 001-33438 | 94-3307935 | ||
(State or other jurisdiction of incorporation or organization) |
(Commission File Number) |
(I.R.S. Employer Identification Number) |
2215 Bridgepointe Parkway, Suite 200, San Mateo, California 94404
(Address of principal executive offices)
(650) 358-3300
(Registrants telephone number, including area code)
N/A
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 8.01. | Other Events. |
On April 17, 2012, NeurogesX, Inc. issued a press release entitled NeurogesX Engages JSB-Partners to Execute Business Development Strategy.
A copy of the press release, dated April 17, 2012, is filed as Exhibit 99.1, to this Current Report on Form 8-K and is incorporated by reference herein. The contents of the press release are deemed to be filed for purposes of the Securities Exchange Act of 1934, as amended.
Item 9.01. | Financial Statements and Exhibits. |
(d) Exhibits.
The following exhibit is filed as part of this Form 8-K.
Exhibit No. |
Description | |
99.1 | NeurogesX Engages JSB-Partners to Execute Business Development Strategy |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
NEUROGESX, INC. | ||||
Date: April 19, 2012 |
By: | /S/ STEPHEN F. GHIGLIERI | ||
Stephen F. Ghiglieri | ||||
Executive Vice President, Chief Operating Officer Chief Financial Officer |
Exhibit List
Exhibit No. |
Description | |
99.1 | NeurogesX Engages JSB-Partners to Execute Business Development Strategy |